CONGRESSES
CONGRESSES
Find information on previous and upcoming congresses
View upcoming congresses and filter through abstracts, presentations, and posters from past congresses.
Upcoming congresses
2025 AMCP Congress
BioCryst will attend the 2025 AMCP Congress from March 31 to April 3, 2025.
Browse our archive of congress materials
Filter
Showing 92 Materials
-
Exploring the Role of Disease Burden, Treatment Effectiveness, and Administration Preference on Willingness of Patients With HAE to Change Long-Term Prophylaxis
AAAAI | 2025 | Hereditary Angioedema (HAE) -
HAE attack rates in pediatric patients 2 to <12 years of age with prophylactic berotralstat: results from interim analysis of APeX-P
AAAAI | 2025 | Hereditary Angioedema (HAE) -
Real-world attack rates before and after berotralstat initiation among patients with hereditary angioedema with C1-inhibitor deficiency (type I/II) stratified by monthly baseline HAE attack frequency
AAAAI | 2025 | Hereditary Angioedema (HAE) -
Real-world attack rates before and after berotralstat initiation among patients with hereditary angioedema without C1-inhibitor deficiency (HAE-nl-C1-INH) stratified by monthly baseline HAE attack frequency
AAAAI | 2025 | Hereditary Angioedema (HAE) -
Patient-reported impact of berotralstat as long-term prophylaxis on hereditary angioedema attack frequency and attack severity
AAAAI | 2025 | Hereditary Angioedema (HAE) -
Adverse Health Outcomes and Patient and Physician Perspectives of Attenuated Androgen Use in Hereditary Angioedema
EAACI | 2024 | Hereditary Angioedema (HAE) -
Adherence And Persistence Among Hereditary Angioedema Patients Treated With Berotralstat, Lanadelumab, And Subcutaneous Plasma-Derived C1-Inhibitor
ACAAI | 2024 | Hereditary Angioedema (HAE) -
Real-world effectiveness of berotralstat in HAE with and without C1-inhibitor deficiency
AAAAI | 2024 | Hereditary Angioedema (HAE) -
Real-world effectiveness of berotralstat in HAE with and without C1-inhibitor deficiency
EAC | 2024 | Hereditary Angioedema (HAE) -
Sustained Real-World Attack Reductions Following Berotralstat Initiation Among Patients with Hereditary Angioedema with C1-Inhibitor Deficiency
ACAAI | 2024 | Hereditary Angioedema (HAE)